Literature DB >> 19622522

Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study.

Y A Rajabally1, G Nicolas, F Piéret, P Bouche, P Y K Van den Bergh.   

Abstract

BACKGROUND: Diagnostic criteria for chronic inflammatory demyelinating polyneuropathy (CIDP) have variable sensitivity and specificity. Newly published criteria by Koski et al combine clinical and electrophysiological components, either of which suffices to establish the diagnosis. European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) criteria require mandatory electrophysiology, as do other sets of criteria.
METHODS: The value of the two above-mentioned sets of criteria, on 151 patients with CIDP, and 162 controls with axonal neuropathy, from four European centres was assessed. Results were compared with Van den Bergh and Piéret's criteria and those of the American Academy of Neurology (AAN). The utility of more extensive nerve-conduction studies was ascertained.
RESULTS: Koski et al's criteria had a sensitivity of 63% and specificity of 99.3%. With unilateral, right-sided, forearm/foreleg, four-nerve studies, EFNS/PNS criteria offered a sensitivity of 81.3% and specificity of 96.2% for "definite/probable" CIDP. Van den Bergh and Piéret's criteria had a sensitivity of 79.5% and specificity of 96.9%. AAN criteria were poorly sensitive (45.7%) but highly specific (100%). "Possible" electrophysiological CIDP as per EFNS/PNS criteria were poorly specific (69.2%). More extensive studies increased the diagnostic sensitivity of EFNS/PNS criteria (96.7%) but reduced the specificity (79.3%).
CONCLUSIONS: In our patient populations, the EFNS/PNS criteria were the most sensitive and allowed identification of a highly significantly greater number of patients than Koski et al's criteria. The latter were comparable in specificity with the "definite/probable" EFNS/PNS electrodiagnostic subcategories. More extensive nerve-conduction studies improved diagnostic yield but resulted in loss of specificity.

Entities:  

Mesh:

Year:  2009        PMID: 19622522     DOI: 10.1136/jnnp.2009.179358

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

Review 1.  Acquired neuropathies.

Authors:  Pierre Lozeron; Jean-Marc Trocello; Nathalie Kubis
Journal:  J Neurol       Date:  2013-06-16       Impact factor: 4.849

Review 2.  Advances in the diagnosis, pathogenesis and treatment of CIDP.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

Review 3.  Neuroimaging in diagnosis of atypical polyradiculoneuropathies: report of three cases and review of the literature.

Authors:  Roberto Gasparotti; Marta Lucchetta; Mario Cacciavillani; Walter Neri; Carlo Guidi; Tiziana Cavallaro; Sergio Ferrari; Luca Padua; Chiara Briani
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

4.  Reply: biomarkers of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.

Authors:  Susanna B Park; Jia-Ying Sung; Jowy Tani; Matthew C Kiernan; Cindy S-Y Lin
Journal:  Brain       Date:  2014-09-02       Impact factor: 13.501

5.  Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.

Authors:  Alexander Grimm; Debora Vittore; Victoria Schubert; Maria Rasenack; Bernhard F Décard; Bianka Heiling; Nadin Hammer; Hubertus Axer
Journal:  J Neurol       Date:  2016-03-26       Impact factor: 4.849

Review 6.  Immunotherapy in Peripheral Neuropathies.

Authors:  Jean-Marc Léger; Raquel Guimarães-Costa; Cristina Muntean
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

7.  Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Authors:  Merel C Broers; Carina Bunschoten; Daan Nieboer; Hester F Lingsma; Bart C Jacobs
Journal:  Neuroepidemiology       Date:  2019-01-22       Impact factor: 3.282

Review 8.  Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.

Authors:  Adnan Malik; Rani Berry; Brian M Fung; James H Tabibian
Journal:  Clin J Gastroenterol       Date:  2020-11-04

9.  Evaluation of the EFNS/PNS diagnostic criteria in a cohort of CIDP patients.

Authors:  Diamantis Athanasopoulos; Jeremias Motte; Thomas Grüter; Nuray Köse; Min-Suk Yoon; Susanne Otto; Christiane Schneider-Gold; Ralf Gold; Anna L Fisse; Kalliopi Pitarokoili
Journal:  Ann Clin Transl Neurol       Date:  2021-04-07       Impact factor: 4.511

Review 10.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.